FINWIRES · TerminalLIVE
FINWIRES

Update: STAAR Surgical Shares Rise After Wedbush Upgrade Following Q1 Results

By

(Updates with recent stock movement and upgrade from Wedbush in headline and first two paragraphs.)

STAAR Surgical (STAA) shares rose more than 10% in Thursday afternoon trading after Wedbush Securities upgraded the company's stock following the company's Q1 results that beat market expectations.

The investment firm upgraded the stock to outperform from neutral and adjusted the price target to $40 from $26. Trading volume of STAAR stood at more than 2.7 million shares against a daily average of about 1.3 million.

The company reported Q1 earnings late Wednesday of $0.10 per diluted share, swinging from a loss of $1.10 a year earlier.

Analysts surveyed by FactSet expected a loss of $0.05.

Net sales for the three months ended April 3 rose to $93.5 million from $42.6 million a year earlier.

Analysts polled by FactSet expected $78.7 million.

Price: $32.53, Change: $+3.13, Percent Change: +10.63%

Related Articles

Australia

A2Z Cust2Mate Gets Approval for $30 Million Commercial Credit Line

A2Z Cust2Mate Solutions (AZ) said Thursday it received approval from an Israeli commercial bank for a $30 million commercial line of credit to support the large-scale manufacturing and deployment of its smart shopping carts.The line of credit, which will be secured by purchase orders received by the company, is designated to fund the mass production and deployment of smart carts for existing orders.The approval follows a due diligence process by the bank evaluating the company's technology, purchase orders, and business model, according to A2Z.Shares of A2Z rose more than 4% in Thursday afternoon trading.Price: $6.76, Change: $+0.29, Percent Change: +4.48%

$AZ
Australia

KBR Maintains Quarterly Dividend at $0.165 a Share, Payable on July 15 to Shareholders of Record on June 15

Price: $30.88, Change: $+0.38, Percent Change: +1.25%

$KBR
Australia

Camden Property Trust Shares Fall After Brokerages Cut Price Targets, Downgrade Stock

Camden Property Trust (CPT) shares were down around 1.2% in recent Thursday trading after multiple price target cuts and a rating downgrade.Morgan Stanley lowered its price target to $117 from $119 and kept an equalweight rating. UBS also cut its price target to $106 from $108 and maintained a neutral rating.Meanwhile, Scotiabank downgraded the stock to sector underperform from sector perform and adjusted its price target to $95 from $113.Trading volume stood at over 634,350 shares compared with a daily average of about 1.1 million shares.Price: $104.09, Change: $-1.26, Percent Change: -1.20%

$CPT